| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |